Wellth, a digital health startup that offers small financial rewards for completing health-related tasks, is launching a suite of in-app personalized, predictive health features to help control the leading factors affecting chronic health conditions,…
Continue Reading
What You Should Know:
– CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on…
Continue Reading
Glucose monitoring specialist Dexcom announced it is expanding its diabetes management capabilities by offering direct connectivity to the Apple Watch of its G7 continuous glucose monitoring system through a dedicated Bluetooth connection.The feature allows…
Continue Reading
Rumah Sakit Universitas Indonesia to test South Korean AI-powered diabetes management appKakao Healthcare has signed a memorandum of agreement with state university hospital Rumah Sakit Universitas Indonesia (RSUI) to pilot its latest AI-based diabetes…
Continue Reading
What You Should Know:
– Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous…
Continue Reading
Healthcare providers in Australia have been “slow” in their uptake of remote care technologies, such as remote patient monitoring and digital therapeutics. Despite their wide availability and verifiable and promising benefits, remote care technologies “[don’t]…
Continue Reading
California-based Allez Health, formerly Zense-Life Inc., announced it secured $60 million in Series A+ financing. The round was led by strategic investor Osang Healthcare Co., Ltd., with participation from existing investors.
WHAT IT DOES
Allez Health is…
What You Should Know:
– Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve…
Continue Reading
Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale
Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device
$58 Million in Funding…
